Inventor

ROKBI BACHRA

FR14 patents

⚠️ This page may combine multiple inventors who share the name “ROKBI BACHRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AVENTIS PASTEUR

3 patents

US6835384B1Dec 28, 2004

Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains

AVENTIS PASTEUR6 citations71

US7384768B2Jun 10, 2008

Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus

AVENTIS PASTEUR2 citations60

US7704513B2Apr 27, 2010

Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus

AVENTIS PASTEUR0 citations50

ROKBI BACHRA

2 patents

US8338137B2Dec 25, 2012

Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strains

ROKBI BACHRA5 citations53

US8557537B2Oct 15, 2013

Method for the production of overproducing Staphylococcus aureus strains

ROKBI BACHRA0 citations42

SANOFI PASTEUR

2 patents

US10772946B2Sep 15, 2020

Immunogenic compositions against S. aureus

SANOFI PASTEUR0 citations47

US10232029B2Mar 19, 2019

Compositions comprising N. meningitidis proteins

SANOFI PASTEUR0 citations38

SANOFI PASTEUR SA

1 patent

US9669052B2Jun 6, 2017

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

SANOFI PASTEUR SA1 citations60

AUJAME LUC

1 patent

US8309100B2Nov 13, 2012

Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains

AUJAME LUC2 citations55

SANOFI PASTEUR S A

1 patent

US7863013B2Jan 4, 2011

Method for the production of overproducing Staphylococcus aureus strains

SANOFI PASTEUR S A2 citations54

MISTRETTA NOËLLE

1 patent

US9132181B2Sep 15, 2015

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

MISTRETTA NOËLLE1 citations48

MISTRETTA NOELLE

1 patent

US10137145B2Nov 27, 2018

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

MISTRETTA NOELLE0 citations43

SANOFI PASTEUR INC

1 patent

US12053516B2Aug 6, 2024

Meningococcal B recombinant vaccine

SANOFI PASTEUR INC0 citations36

MAITRE-WILMOTTE GHISLAINE

1 patent

US8673617B2Mar 18, 2014

Culture medium for Haemophilus influenzae type B

MAITRE-WILMOTTE GHISLAINE0 citations35